Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung … – Wall Street Journal

Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung
Wall Street Journal
Secondary efficacy endpoints in the proof-of-concept study were also achieved, including reduced short-acting beta agonist use; asthma control; forced vital capacity improvement; symptom-free days during treatment; and improvement in rhinasthma and 
Array BioPharma: ARRY-502 Meets Primary And Secondary Endpoints In RTT News
Array Biopharma To Report Top-line Results From ARRY-502 Asthma TrialBenzinga

all 3 news articles »

View full post on asthma – Google News

DA Candidate Ken Thompson Identifies Brooklyn Heights as High Asthma Zone – Brooklyn Heights Blog (blog)

DA Candidate Ken Thompson Identifies Brooklyn Heights as High Asthma Zone
Brooklyn Heights Blog (blog)
In his discussion of environmental problems in Brooklyn, he notes that Brooklyn Heights is one of five borough neighborhoods–the others are Bushwick, Downtown Brooklyn, Park Slope, and Williamsburg–having asthma rates that exceed the national
Ken Thompson unveils plans for environmental protection unit at Brooklyn DA's Brooklyn Daily Eagle

all 2 news articles »

View full post on asthma – Google News

Occupational asthma markers: Candidate proteins for exposure to toluene … – spectroscopyNOW.com


spectroscopyNOW.com

Occupational asthma markers: Candidate proteins for exposure to toluene
spectroscopyNOW.com
Occupational asthma is one of those furtive industrial hazards, sneaking up on its victims unawares while they go about their jobs. Induced by exposure to chemicals that irritate the airways, OA can be a debilitating condition that lays workers low for

View full post on asthma – Google News

Targacept says drug candidate worked as an asthma treatment, but fails as … – Greenfield Daily Reporter

Targacept says drug candidate worked as an asthma treatment, but fails as
Greenfield Daily Reporter
AP WINSTON-SALEM, NC — Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients who were
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of MarketWatch (press release)
Asthma drug shows promise, diabetes study fails in Targacept phase 2 trialsMedCity News
Targacept reports mixed data from two trialsReuters
Bizjournals.com –FierceBiotech
all 28 news articles »

View full post on asthma – Google News

Targacept says drug candidate worked as an asthma treatment, but fails as … – The Republic

Targacept says drug candidate worked as an asthma treatment, but fails as
The Republic
AP WINSTON-SALEM, NC — Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients who were
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of MarketWatch (press release)
Asthma drug shows promise, diabetes study fails in Targacept phase 2 trialsMedCity News
Targacept reports mixed data from two trialsReuters
Bizjournals.com –FierceBiotech
all 25 news articles »

View full post on asthma – Google News

The asthma candidate gene NPSR1 mediates isoform specific downstream signalling – 7thSpace Interactive (press release)

The asthma candidate gene NPSR1 mediates isoform specific downstream signalling
7thSpace Interactive (press release)
Neuropeptide S Receptor 1 (NPSR1, GPRA, GPR154) was first identified as an asthma candidate gene through positional cloning and has since been replicated as an asthma and allergy susceptibility gene in several independent association studies.

View full post on asthma – Google News